RxDoctor Payments Data

John Spindler

Physician Assistant · Schenectady, NYNPI 1326159054

Payments from drug & device makers

$753in general payments, 2019–2025

Across 43 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$260
  • GSK$174
  • Novo Nordisk$127
  • Xeris Pharmaceuticals, Inc.$75
  • Merck$42
  • Novartis$40
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$753 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$59,270
Medicare patients
180
Services billed
1,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$96,488
OzempicSemaglutide69$83,190
RybelsusSemaglutide31$72,379
TrulicityDulaglutide36$54,525
XareltoRivaroxaban26$39,471
EliquisApixaban24$21,046
MounjaroTirzepatide13$20,621
Spiriva RespimatTiotropium Bromide20$13,437
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$7,912
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate18$4,847
Rosuvastatin Calcium223$4,099
Atorvastatin Calcium293$3,695
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,190
SymbicortBudesonide/Formoterol Fumarate11$2,638
Albuterol Sulfate HfaAlbuterol Sulfate81$2,302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$127$155,569100 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Schenectady

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →